oxazoles has been researched along with sulforaphane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cholujova, D; Csaderova, L; Fojtu, M; Gronesova, P; Hudecova, S; Kopacek, J; Krizanova, O; Markova, J; Novakova, M; Pastorek, M; Pastorekova, S; Sedlak, J; Simko, V; Sirova, M; Stracina, T; Svastova, E | 1 |
Amato, CM; Bereman, M; Fricke, A; Marella, S; McCoy, KA; Mogus, JP | 1 |
2 other study(ies) available for oxazoles and sulforaphane
Article | Year |
---|---|
Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
Topics: Animals; Anticarcinogenic Agents; Antioxidant Response Elements; Apoptosis; Calcium; Cell Line, Tumor; Cell Nucleus; Endoplasmic Reticulum; Female; Heme Oxygenase-1; Humans; Inositol 1,4,5-Trisphosphate Receptors; Isothiocyanates; Kruppel-Like Transcription Factors; Macrocyclic Compounds; Mice; Mice, Nude; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Ovarian Neoplasms; Oxazoles; Oxidative Stress; Reactive Oxygen Species; Sulfoxides; Transcriptional Activation; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |
An experimental evaluation of the efficacy of perinatal sulforaphane supplementation to decrease the incidence and severity of vinclozolin-induced hypospadias in the mouse model.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Environmental Pollutants; Female; Humans; Hypospadias; Incidence; Isothiocyanates; Male; Mice; NF-E2-Related Factor 2; Oxazoles; Pregnancy; Sulfoxides | 2022 |